in plates coated with poly-D-lysine (0.1 mg/ml, Sigma-Aldrich, USA) at a density of 1 million cells per 9.6 cm 2 . Neurons were cultured at 37°C with 5% CO 2 and 95% humidity with a half-medium change every 2 days. Cortical neurons were allowed to differentiate for at least seven days in vitro (DIV 7) prior to treatment (7, 8) . All reagents were purchased from Thermo Fisher Scientific, (USA) unless specified.
For specific sets of experiments cortical cultures generated from 5-HT 2A -/-mouse embryos were transduced with rAAV8-CaMKIIα-GFP-Cre (UNC Vector Core facility, NC, 
Drug treatment paradigms
For dose response studies, rat cortical neurons were treated with 5-HT (10, 50 and 100 µM) for six days. For mitochondrial marker analysis, mitotracker imaging experiments and reactive oxygen species (ROS) measurements, rat cortical cultures were treated with 5-HT (100 µM) for six days. once daily for 10 days prior to sacrifice 2 h post the final CNO injection. All compounds were purchased from Tocris Bioscience (United Kingdom), except 5-HT, DOI, norepinephrine, WAY100,635, EX-527, H 2 O 2 and kainate (Sigma-Aldrich, USA). The concentration of neurotransmitters used was based on prior studies (9) (10) (11) (12) (13) (14) .
Quantitative real time polymerase chain reaction
RNA was extracted from cortical neurons using the commercially available RNeasy
Micro/Mini kit (Qiagen). 50 ng of RNA per sample was reverse transcribed to cDNA using random hexamers and the Superscript IV reverse transcription kit (Invitrogen, USA).
Quantitative real time PCR was performed using gene specific primers and cDNA was amplified in a Light Cycler 96 (Roche Applied Science, Switzerland) real time PCR system using KAPA SYBR® FAST Universal 2X qPCR Master Mix (Kapa Biosystems). Gene expression levels were normalized to the endogenous 18S ribosomal RNA per sample, and the relative expression levels between control and treated samples were computed by the Ct method, as described previously (15) . Data are represented as fold change ± SEM as compared to control.
Mitochondrial DNA levels
Mitochondrial DNA (mtDNA) levels were compared in control versus treated cortical neurons by quantitative real time PCR. Total DNA was extracted from cells using the commercially available All Prep DNA/RNA Mini kit (Qiagen, Germany). Levels of cytochrome B -a mitochondrial genome encoded gene were normalized to levels of a nuclear encoded gene cytochrome C. Relative mitochondrial DNA levels between groups were quantified by the Ct method as described previously (16) .
Immunofluorescence
For immunostaining, cortical neurons were fixed in 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, followed by blocking in 10% horse serum. Cells were then incubated with primary antibodies, which included the rabbit anti-VDAC (1:200 respectively and images were captured on the Olympus Fluoview 1000 confocal laser scanning microscope.
Mitotracker Staining
Cortical neurons were loaded with mitotracker green (20 nM, Invitrogen) for 45 min, and images were recorded using an Olympus Fluoview 1000 confocal laser scanning microscope. The intensity of staining in neurites was quantitated over a distance of 10 m commencing from the point proximal to the cell body using ImageJ® software (NIH, USA) in 15-20 neurons per treatment condition per experiment.
Western blot analysis
Control and treated cortical neuron cultures were lysed in ice cold 
Cellular ATP
Cortical neurons were lysed in boiling water and lysate was centrifuged at 12,000 rpm for 20 min at 4°C. The ATP levels in the supernatant were quantified using the ATP bioluminescent assay kit (Sigma-Aldrich), by mixing the luciferin substrate and luciferase enzyme mix with equal amounts of supernatant in a 96 well plate. The light emitted is proportional to the ATP consumed in the reaction, and was measured using a luminometer (Berthold Technologies, Germany). ATP levels were normalized to protein content of each sample, estimated using a BCA protein assay kit (Sigma-Aldrich) and expressed as fold change of treated over control.
Mitochondrial Respiration Analysis
Cortical neurons were seeded at an equal density of 10 x 10 4 cells per well of the Seahorse XF24 cell culture microplate and differentiated in Neurobasal medium. Cells were treated with 5-HT or DOI for 72 h, with 4-5 replicate wells per group. On the day of the assay, control and treated neurons were washed twice in assay medium, and 500 μL of assay medium pre-warmed to 37°C, was added in each well. Assay medium comprised of Seahorse XF base medium supplemented with 25 mM glucose (Sigma), 1 mM pyruvate (Sigma), 2 mM glutamine (Thermo Fisher Scientific) pH 7.4. 2% B27 (Thermo Fisher Scientific) was added prior to the addition of the medium to the wells. The plate was equilibrated in a non-CO 2 incubator for 45 min at 37°C, and thereafter loaded into the Seahorse XF24 analyzer.
Oxygen Consumption rate (OCR) (pmol min −1 ) was measured baseline in assay medium, and thereafter cells were exposed to sequential injections of oligomycin (1 µM, ATP synthase complex V inhibitor), FCCP (2 µM, collapses the proton gradient, disrupts the mitochondrial membrane potential and uncouples oxygen consumption from ATP production) and rotenone (0.5 µM, complex I inhibitor), with three consecutive OCR measurements taken after each injection. OCR measurements at baseline and following the three serial injections, were used to calculate basal respiration, ATP production, maximal respiration, non-mitochondrial respiration and spare respiratory capacity. OCR measurements were normalized to blank wells and cell count in each well, and expressed as pmol/min/10repeated thrice and values from all the repeats were collated when calculating mitochondrial parameters. A representative trace of OCR per treatment condition is depicted.
Isolation of mitochondria and bioenergetic measurements
Mitochondria were isolated from the prefrontal cortex (PFC) of vehicle (saline) treated and DOI injected Sprague Dawley rats (5 -6 months), by modifying the differential centrifugation protocol as described in Rogers et al., 2011 (17) . In brief, tissue was homogenized in ice-cold mitochondrial isolation buffer (MSHE+BSA, containing 210 mM mannitol, 70 mM sucrose, 5 mM HEPES, 1 mM EGTA, and 0.5% (w/v) fatty acid-free BSA, pH 7.2) using a dounce homogenizer (4 strokes). Following centrifugation at 800 g for 10 minutes (4°C), the supernatant was collected in a separate tube and centrifuged at 8,000 g for 10 minutes (4°C). The pellet was suspended in MSHE+BSA, and the centrifugation procedure was repeated. Finally, the pellet was resuspended in a small volume of ice-cold mitochondrial assay buffer (MAS+BSA, containing 220 mM mannitol, 70 mM sucrose, 10 mM KH 2 PO4, 5 mM MgCl 2 , 2 mM HEPES, 1 mM EGTA and 0.5% (W/V) fatty acid-free BSA, pH 7.2). Protein concentrations were determined using BCA estimations using BSA as standard, and 10 μg of mitochondrial preparations were used for bioenergetic analysis immediately after the isolation. Mitochondria were plated (10 μg/50 µl) in Seahorse XFe24 
Cellular ROS Measurement
To assess levels of cellular reactive oxygen species (ROS), carboxy-H 2 DCFDA (25 µM) was added to the medium for 30 min at 37°C. Cells were then washed twice and images were captured using the Olympus Fluoview 1000 confocal laser scanning microscope.
Alternatively, to quantitate the fluorescence, cells were lysed in RIPA buffer and fluorescence was read per treatment per well at excitation/emission of 495/529nm, and normalized to protein content per well. Protein was estimated by BCA method (Sigma).
Osmotic Minipump Surgery
Sprague-Dawley rats (males, 5-6 months) were anaesthetized using isoflurane (1%-1.5%) in oxygen. Animals were placed in a stereotactic apparatus (Stoelting Instruments, USA) and cannulae were implanted in the cortex (relative to Bregma: 0.9 mm posterior, 2 mm lateral and 2 mm ventral) and secured using dental cement and anchor screws. Osmotic minipumps (Alzet model 2001; flow rate 1 μl/h, 7 d pump) were primed according to the procedure described by the manufacturer with either Phosphate buffered saline (PBS) or 10
M 5-HT (in 200 μl PBS). In brief, all pumps were placed in beakers containing sterile PBS and primed overnight at 37⁰C in an incubator. Pumps were attached to the cannulae, and inserted in a subcutaneous pocket made at the back of the animal, and animals were closely monitored for post surgical recovery.
Data Availability Statement
Detailed protocol, raw data and materials will be made available upon request. This manuscript does not contain any omics datasets. 
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